A first-in-human single ascending dose study of a monoclonal antibody against the ANGPTL3/8 complex in subjects with mixed hyperlipidemia. (August 2022) - Gaudet, D.; Gonciarz, M.; Shen, X.; Mullins, G.; Leohr, J.K.; Benichou, O.; Beyer, T.; Ruotolo, G.